0000899243-18-019865.txt : 20180713
0000899243-18-019865.hdr.sgml : 20180713
20180713210252
ACCESSION NUMBER: 0000899243-18-019865
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180531
FILED AS OF DATE: 20180713
DATE AS OF CHANGE: 20180713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poma Eric E
CENTRAL INDEX KEY: 0001339484
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 18953439
MAIL ADDRESS:
STREET 1: C/O INNOVIVE PHARMACEUTICALS, INC.
STREET 2: 555 MADISON AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2018-05-31
2018-06-04
0
0001183765
Molecular Templates, Inc.
MTEM
0001339484
Poma Eric E
C/O MOLECULAR TEMPLATES, INC.
9301 AMBERGLEN BLVD., SUITE 100
AUSTIN
TX
78729
1
1
0
0
See Remarks
Stock Option (right to buy)
6.31
2018-05-31
4
A
0
585126
0.00
A
2028-05-31
Common Stock
585126
585126
D
25% of the total number of shares subject to the option shall vest on May 31, 2019, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months.
Chief Executive Officer and Chief Scientific Officer
This amendment to Form 4 is filed to reflect that the correct number options granted in the reported transaction is 585,126.
/s/ Eric E. Poma
2018-07-13